Cargando…

Anticancer Nanotherapeutics in Clinical Trials: The Work behind Clinical Translation of Nanomedicine

The ultimate goal of nanomedicine has always been the generation of translational technologies that can ameliorate current therapies. Cancer disease represented the primary target of nanotechnology applied to medicine, since its clinical management is characterized by very toxic therapeutics. In thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parodi, Alessandro, Kolesova, Ekaterina P., Voronina, Maya V., Frolova, Anastasia S., Kostyushev, Dmitry, Trushina, Daria B., Akasov, Roman, Pallaeva, Tatiana, Zamyatnin, Andrey A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656556/ https://www.ncbi.nlm.nih.gov/pubmed/36362156 http://dx.doi.org/10.3390/ijms232113368

Ejemplares similares

Nanomedicine for increasing the oral bioavailability of cancer treatments
por: Parodi, Alessandro, et al.
Publicado: (2021)

Proteolytic Resistance Determines Albumin Nanoparticle Drug Delivery Properties and Increases Cathepsin B, D, and G Expression
por: Kolesova, Ekaterina P., et al.
Publicado: (2023)

Chemoreactive Nanotherapeutics by Metal Peroxide Based Nanomedicine
por: Hu, Hui, et al.
Publicado: (2020)

Smart Delivery Systems Responsive to Cathepsin B Activity for Cancer Treatment
por: Egorova, Vera S., et al.
Publicado: (2023)

Particle Nanoarchitectonics for Nanomedicine and Nanotherapeutic Drugs with Special Emphasis on Nasal Drugs and Aging
por: Aziz, Tariq, et al.
Publicado: (2023)

Hydroxychloroquine Enhances Cytotoxic Properties of Extracellular Vesicles and Extracellular Vesicle–Mimetic Nanovesicles Loaded with Chemotherapeutics
por: Brezgin, Sergey, et al.
Publicado: (2023)

In Silico, In Vitro, and Clinical Investigations of Cathepsin B and Stefin A mRNA Expression and a Correlation Analysis in Kidney Cancer
por: Rudzinska-Radecka, Magdalena, et al.
Publicado: (2022)

External and Internal Stimuli-Responsive Metallic Nanotherapeutics for Enhanced Anticancer Therapy
por: Mohapatra, Adityanarayan, et al.
Publicado: (2021)

Past, Present, and Future of Anticancer Nanomedicine
por: Kim, Kyungeun, et al.
Publicado: (2020)

H-Dot Mediated Nanotherapeutics Mitigate Systemic Toxicity of Platinum-Based Anticancer Drugs
por: Yamashita, Atsushi, et al.
Publicado: (2023)

Clinical Advances of siRNA-Based Nanotherapeutics for Cancer Treatment
por: Hattab, Dima, et al.
Publicado: (2021)

Nanotherapeutics in transplantation: How do we get to clinical implementation?
por: Plumblee, Leah, et al.
Publicado: (2022)

Advances in personalized nanotherapeutics
por: Kaushik, Ajeet, et al.
Publicado: (2017)

Polymeric nanomaterials for nanotherapeutics
por: Vasile, Cornelia
Publicado: (2018)

Targeted nanotherapeutics in cancer
por: Shiekh, Farooq A
Publicado: (2014)

New Perspectives on the Role of Nuclear Proteases in Cell Death Pathways
por: Frolova, Anastasia S., et al.
Publicado: (2023)

Zebrafish as a Model for Anticancer Nanomedicine Studies
por: Al-Thani, Hissa F., et al.
Publicado: (2021)

Unravelling the Network of Nuclear Matrix Metalloproteinases for Targeted Drug Design
por: Frolova, Anastasia S., et al.
Publicado: (2020)

Depleting hepatitis B virus relaxed circular DNA is necessary for resolution of infection by CRISPR-Cas9
por: Kostyushev, Dmitry, et al.
Publicado: (2023)

Nanotherapeutics for treating coronavirus diseases
por: Gunathilake, Thennakoon M. Sampath U., et al.
Publicado: (2021)

Smart Nanotherapeutics and Lung Cancer
por: Doroudian, Mohammad, et al.
Publicado: (2021)

Nanotherapeutics: Engineering Cell Membrane‐Based Nanotherapeutics to Target Inflammation (Adv. Sci. 15/2019)
por: Yan, Huize, et al.
Publicado: (2019)

Emerging Nanotherapeutic Approaches to Overcome Drug Resistance in Cancers with Update on Clinical Trials
por: Bukhari, Syed Nasir Abbas
Publicado: (2022)

Challenges in nanomedicine clinical translation
por: Metselaar, Josbert M., et al.
Publicado: (2020)

The application of nanomedicine in clinical settings
por: Zhao, Qingsong, et al.
Publicado: (2023)

Reduction of graphene oxide by resveratrol: a novel and simple biological method for the synthesis of an effective anticancer nanotherapeutic molecule
por: Gurunathan, Sangiliyandi, et al.
Publicado: (2015)

Genetic Factors of Predisposition and Clinical Characteristics of Rheumatoid Arthritis in Russian Patients
por: Vetchinkina, Ekaterina A., et al.
Publicado: (2021)

Polymeric Core–Shell Combinatorial Nanomedicine for Synergistic Anticancer Therapy
por: Shanavas, Asifkhan, et al.
Publicado: (2019)

Peptide-siRNA nanotherapeutics in arthritis
por: Pham, Christine T.N., et al.
Publicado: (2015)

RNA Nanotherapeutics for the Amelioration of Astroglial Reactivity
por: Smith, Jayden A., et al.
Publicado: (2017)

Nanotherapeutics for Treatment of Pulmonary Arterial Hypertension
por: Segura-Ibarra, Victor, et al.
Publicado: (2018)

Extracellular Vesicles as Nanotherapeutics for Parkinson’s Disease
por: Leggio, Loredana, et al.
Publicado: (2020)

Microglia-targeting nanotherapeutics for neurodegenerative diseases
por: Zhao, Nanxia, et al.
Publicado: (2020)

Recent Advances in Nanotherapeutics for Multiple Myeloma
por: Iannazzo, Daniela, et al.
Publicado: (2020)

Potential nanotherapeutic strategies for perioperative stroke
por: An, Jingyi, et al.
Publicado: (2022)

Editorial: Oral Nanotherapeutics for Colon Diseases
por: Duan, Lian, et al.
Publicado: (2021)

Nanotherapeutic Intervention in Photodynamic Therapy for Cancer
por: Itoo, Asif Mohd, et al.
Publicado: (2022)

Lipid-engineered nanotherapeutics for cancer management
por: Fernandez-Fernandez, Alicia, et al.
Publicado: (2023)

Recent Advances in Nanotherapeutics for Neurological Disorders
por: Vashist, Arti, et al.
Publicado: (2023)

New Advances in the Understanding of Proteases as Diagnostic and Pharmaceutical Targets in Homeostatic and Pathologic Conditions
por: Zamyatnin, Andrey A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t9vplf7erat3vj7j210meubdcr